LeonaBio, Inc. Operating Income Loss

• LeonaBio, Inc. showed a decrease of -1.4% in Operating Income Loss from 2024 to 2025.
• This data is from LeonaBio, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2019 to 2025), LeonaBio, Inc.'s Operating Income Loss has declined by 1,776.8%.
• Historical annual values: Fiscal year 2025: -$102.27 million | Fiscal year 2024: -$100.90 million | Fiscal year 2023: -$125.47 million | Fiscal year 2022: -$104.02 million | Fiscal year 2021: -$64.02 million | Fiscal year 2020: -$20.00 million | Fiscal year 2019: -$5.45 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026